56.99 USD
+0.02 (+0.04%)
At close: Aug 15, 2024
56.99 USD
0 (0%)
After Hours: 8/15/2024, 8:13:37 PM
MORF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 524 industry peers in the Biotechnology industry. MORF has a great financial health rating, but its profitability evaluates not so good. MORF is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- MORF had negative earnings in the past year.
- MORF had a negative operating cash flow in the past year.
- MORF had negative earnings in each of the past 5 years.
- MORF had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- MORF's Return On Assets of -27.83% is fine compared to the rest of the industry. MORF outperforms 71.70% of its industry peers.
- MORF has a better Return On Equity (-29.08%) than 81.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.83% | ||
| ROE | -29.08% | ||
| ROIC | N/A |
ROA(3y)-19.83%
ROA(5y)-19.11%
ROE(3y)-22.37%
ROE(5y)-25.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for MORF so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- MORF does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for MORF has been increased compared to 1 year ago.
- There is no outstanding debt for MORF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- MORF has an Altman-Z score of 60.78. This indicates that MORF is financially healthy and has little risk of bankruptcy at the moment.
- MORF has a Altman-Z score of 60.78. This is amongst the best in the industry. MORF outperforms 98.42% of its industry peers.
- MORF has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 60.78 |
ROIC/WACCN/A
WACC10.56%
2.3 Liquidity
- A Current Ratio of 24.13 indicates that MORF has no problem at all paying its short term obligations.
- MORF has a Current ratio of 24.13. This is amongst the best in the industry. MORF outperforms 95.43% of its industry peers.
- A Quick Ratio of 24.13 indicates that MORF has no problem at all paying its short term obligations.
- MORF's Quick ratio of 24.13 is amongst the best of the industry. MORF outperforms 95.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 24.13 | ||
| Quick Ratio | 24.13 |
3. Growth
3.1 Past
- The earnings per share for MORF have decreased strongly by -15.74% in the last year.
- The Revenue for MORF has decreased by -100.00% in the past year. This is quite bad
- Measured over the past years, MORF shows a very negative growth in Revenue. The Revenue has been decreasing by -31.12% on average per year.
EPS 1Y (TTM)-15.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)-100%
Revenue growth 3Y-77.37%
Revenue growth 5Y-31.12%
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, MORF will show a small growth in Earnings Per Share. The EPS will grow by 0.11% on average per year.
- The Revenue is expected to grow by 213.82% on average over the next years. This is a very strong growth
EPS Next Y-16.05%
EPS Next 2Y-11.1%
EPS Next 3Y-8.78%
EPS Next 5Y0.11%
Revenue Next Year-50.42%
Revenue Next 2Y-24.72%
Revenue Next 3Y-7.43%
Revenue Next 5Y213.82%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- MORF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year MORF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- MORF's earnings are expected to decrease with -8.78% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.1%
EPS Next 3Y-8.78%
5. Dividend
5.1 Amount
- No dividends for MORF!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MORPHIC HOLDING INC / MORF FAQ
Can you provide the ChartMill fundamental rating for MORPHIC HOLDING INC?
ChartMill assigns a fundamental rating of 3 / 10 to MORF.
What is the valuation status for MORF stock?
ChartMill assigns a valuation rating of 0 / 10 to MORPHIC HOLDING INC (MORF). This can be considered as Overvalued.
How profitable is MORPHIC HOLDING INC (MORF) stock?
MORPHIC HOLDING INC (MORF) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for MORF stock?
The Earnings per Share (EPS) of MORPHIC HOLDING INC (MORF) is expected to decline by -16.05% in the next year.